carbamates and laromustine

carbamates has been researched along with laromustine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buros, CM; Gerber, SA; Klinkerch, EJ; Kraus, TJ; Rice, KP; Schleicher, TR1
Cincotta, DJ; Ghazvinian, R; He, Y; Ji, W; Li, Y; Min, W; Praggastis, A; Rice, KP; Yang, M; Zhou, HJ1

Other Studies

2 other study(ies) available for carbamates and laromustine

ArticleYear
Thioredoxin reductase is inhibited by the carbamoylating activity of the anticancer sulfonylhydrazine drug laromustine.
    Molecular and cellular biochemistry, 2012, Volume: 370, Issue:1-2

    Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Carbamates; Carmustine; Cell Line, Tumor; Cysteine; Drug Screening Assays, Antitumor; Hydrazines; Hydrogen-Ion Concentration; Isocyanates; Mice; Molecular Sequence Data; Peptides; Rats; Sulfonamides; Tandem Mass Spectrometry; Thioredoxin-Disulfide Reductase; Time Factors

2012
Carbamoylating activity associated with the activation of the antitumor agent laromustine inhibits angiogenesis by inducing ASK1-dependent endothelial cell death.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: Animals; Antineoplastic Agents; Biocatalysis; Carbamates; Cattle; Cell Death; Cells, Cultured; Endothelial Cells; Humans; Hydrazines; Immunoblotting; Isocyanates; MAP Kinase Kinase Kinase 5; Mitogen-Activated Protein Kinase 8; Neovascularization, Physiologic; Signal Transduction; Sulfonamides; Thioredoxin Reductase 1; Thioredoxins

2014